Zanubrutinib Deemed Safer Than Ibrutinib for Waldenström Macroglobulinemia
Zanubrutinib is as effective as — but safer than — ibrutinib for patients with Waldenström macroglobulinemia, a phase 3 trial suggests.
Diagnosis & Disease Information
How Housing Insecurity Impacts Cancer Patients
Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.
Failed Oncology Trials May Cost Up to $60 Billion Per Year
Researchers have estimated that failed oncology trials cost about $50 billion to $60 billion each year.
How Transportation Insecurity Impacts Cancer Patients
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
Score Can Predict Risk of Second Cancers in Pediatric Cancer Survivors
A polygenic risk score can predict the risk of second malignant neoplasms in pediatric cancer survivors who were treated with chemotherapy, according to researchers.
Prior Authorization Requirements for Oral Cancer Drugs Have Increased Over Time
Prior authorization requirements for oral cancer drugs on Medicare part D formularies have increased in recent years, research suggests.
Lack of Sleep Linked to Increased Risk of Cancer
Getting less than 6 hours of sleep each night was associated with an increased risk of cancer in a large study.
Wastage of Oral Cancer Drugs Costs More Than $4000 per Patient, Study Suggests
Researchers studied 22 oral cancer drugs and found that wastage due to dose modifications or discontinuations resulted in a mean cost of $4290 per patient.
Body Composition Can Change During Chemo in Young Patients With Lymphoma, Rhabdomyosarcoma
Young patients with lymphoma or rhabdomyosarcoma may experience changes in body composition during chemotherapy, research suggests.
Increasing Doses May Improve Efficacy of COVID-19 Vaccines in Cancer Patients
After 3 or 4 doses, mRNA-based COVID-19 vaccines are similarly effective in patients with cancer and the general population, a study suggests.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...